The Hyper-Commons: how open science prizes can expand and level the medical research playing field.
The largest industry in America is increasingly incapable of serving its customers. Over-fencing of the information commons has led to unaffordable medicine, for want of which millions of Americans and people around the world go without lifesaving treatments. Eliminating patent distribution exclusivity altogether, however, is not feasible, given the entrenched nature of the health-care industry. This paper proposes a program of voluntary Open Science Prizes that would draw large numbers of new players, who would in turn produce much new medical innovation, provide academic priority recognition, and develop a growing body of patent-beating prior art that would serve as public domain firewalls on a new supranational Hyper-Commons.
Hynek
Paul
P
Duborne Corporation, Santa Monica, CA 90034, USA. paulhynek@pobox.com
D001363:Awards and Prizes; D035843:Biomedical Research / Q000331:legislation & jurisprudence*; D016265:Conflict of Interest; D009042:Motivation; D010330:Patents as Topic; D014481:United States; D014486:United States Food and Drug Administration